Drug trials in dementia: challenging ethical dilemmas.

Drug trials in dementia: challenging ethical dilemmas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Drug trials in dementia: challenging ethical dilemmas. Abstract Text:

Amos D Korczyn,Amos D Korczyn,

Advances in the treatment of demented individuals is critically dependent upon experimental administration of new drugs to such people, who, by definition, frequently cannot provide informed consent. Ethical problems associated with studies on demented individuals are therefore of great importance. While there is some similarity to other groups (children, psychotic individuals and patients in coma) there also exist several differences. Obtaining an informed consent from a dementing individual is always problematic. Advance directives are helpful to caregivers and patients should be encouraged, at early stages of the disease, to provide them. Participation in drug studies carries inherent benefits to patients, but at the same time exposes them to risks and discomforts which should be monitored and reviewed more intensively than in studies on cognitively intact individuals. The vulnerability of demented people and their dependence requires special attention by the institutional review board (IRB), unique items to be included in the study protocols and consent forms, etc. Representatives of patients' advocacy groups can make important contributions to the IRB, to serve the best interests of the patient and prevent exploitation by the industry as well as by researchers, and honoring the autonomy of the patients. It would be helpful and justified to enable subjects to continue in the study in an open-label design in this situation, once they sign a suitable informed consent. A no-fault insurance could be provided to the patient in this situation.

Drug trials in dementia: challenging ethical dilemmas. Publishing Authors By Initials

AD Korczyn,AD Korczyn,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Drug trials in dementia: challenging ethical dilemmas. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current Alzheimer research

VOLUME: 4

Page Numbers: 468-72

Journal Abbreviation:

ISSN: 1567-2050

DAY: 2

MONTH: Sep

YEAR: 2007

Drug trials in dementia: challenging ethical dilemmas. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101208441

Drug trials in dementia: challenging ethical dilemmas. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Drug trials in dementia: challenging ethical dilemmas. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Drug trials in dementia: challenging ethical dilemmas.

AFFILIATION: The Sieratzki Chair of Neurology, Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv, Israel. neuro13@post.tau.ac.il

Country: United Arab Emirates

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Alzheimer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Drug trials in dementia: challenging ethical dilemmas Related Publications

• Aetiology of Bell's palsy.
• Ariel Sharon's illness.
• Cerebral atherosclerosis in Parkinsonian patients.
• Chapter 9 GM(2) gangliosidoses.
• Cold pressor test in tetraplegia and paraplegia suggests an independent role of the thoracic spinal cord in the hemodynamic responses to cold.
• Denbufylline in dementia: a double-blind controlled study.
• Drug trials in dementia: challenging ethical dilemmas.
• Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls.
• Fasting headache, weight loss, and dehydration.
• Gilles de la Tourette syndrome: EEG and mapping.
• Hiccup.
• Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer's disease.
• MRI parameters of Alzheimer's disease in an Arab population of Wadi Ara, Israel.
• On the origin of the Hering-Traube waves (HTW).
• Periodic lateralized epileptiform discharges (PLEDs) following stroke are associated with metabolic abnormalities.
• Postmeningitis headache.
• Should sleep EEG record always be performed after sleep deprivation?
• Survival in Parkinson's disease: the effect of dementia.
• The amyloid cascade hypothesis.
• Thymectomy for myasthenia gravis.
• Treatment of advanced Alzheimer's disease with cholinesterase inhibitors.
• Vascular parkinsonism.
• Waardenburg syndrome with a fixed dilated pupil.
• [Depression precedes development of dementia]